Literature DB >> 8976826

Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients.

R Heylen1, R Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976826      PMCID: PMC1195670          DOI: 10.1136/sti.72.4.237

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


× No keyword cloud information.
  51 in total

1.  Fluconazole and enhanced effect of rifabutin prophylaxis.

Authors:  P K Narang; C B Trapnell; J R Schoenfelder; J P Lavelle; J R Bianchine
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245

2.  Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole.

Authors:  J Drayton; G Dickinson; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1994-02       Impact factor: 9.079

3.  Possible interaction between phenobarbital, carbamazepine and itraconazole.

Authors:  M Bonay; A P Jonville-Bera; P Diot; E Lemarie; M Lavandier; E Autret
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

4.  Rifabutin prophylaxis and uveitis.

Authors:  J D Fuller; L E Stanfield; D E Craven
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245

5.  Rifabutin and uveitis.

Authors:  M O Frank; M B Graham; B Wispelway
Journal:  N Engl J Med       Date:  1994-03-24       Impact factor: 91.245

Review 6.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part I).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

7.  Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

Authors:  K T Olkkola; J T Backman; P J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  1994-05       Impact factor: 6.875

Review 8.  Fluconazole-induced symptomatic phenytoin toxicity.

Authors:  R M Cadle; G J Zenon; M C Rodriguez-Barradas; R J Hamill
Journal:  Ann Pharmacother       Date:  1994-02       Impact factor: 3.154

9.  Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics.

Authors:  P K Honig; D C Wortham; R Hull; K Zamani; J E Smith; L R Cantilena
Journal:  J Clin Pharmacol       Date:  1993-12       Impact factor: 3.126

10.  Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection.

Authors:  M A Jacobson; D Yajko; D Northfelt; E Charlebois; D Gary; C Brosgart; C A Sanders; W K Hadley
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

View more
  4 in total

1.  Extrapulmonary tuberculosis masking disseminated histoplasmosis in AIDS.

Authors:  L Greene; B Peters; S B Lucas; A L Pozniak
Journal:  Sex Transm Infect       Date:  2000-02       Impact factor: 3.519

2.  Reporting adverse drug reactions in HIV infection.

Authors:  P R Arlett; E H Lee; M Hooker; J H Darbyshire; A M Breckenridge
Journal:  Genitourin Med       Date:  1997-10

Review 3.  Pharmacokinetic factors in the modern drug treatment of tuberculosis.

Authors:  J G Douglas; M J McLeod
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

4.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.